Strategic Partnerships BioConnection has a track record of collaborations with biotech players (e.g., Infant Bacterial Therapeutics) and active engagement in end-to-end manufacturing partnerships, suggesting a strong opportunity to position as a scalable CMOs partner for early-stage and later-stage injectable biologics and personalized medicines.

Comprehensive CMO Offering With capabilities spanning CMC, fill and finish, lyophilization, small-scale hand fill for personalized medicines, toxicology material supply, and PPQ preparation, BioConnection can be pitched as a one-stop shop for companies seeking streamlined regulatory-ready manufacturing and tech transfer.

Global Quality Footprint The FDA and EMA-certified facility in Oss plus a focus on compliant, high-quality production for clinical and market launch materials positions BioConnection as a reliable partner for brands aiming to de-risk GMP transitions and accelerate time-to-market.

Growth Through Leadership Recent leadership appointments and recognition as European Company of the Year indicate a growth-oriented organization with vision and governance that can support scaled commercial engagements and strategic co-development deals.

Market Positioning Operating in a mid-market tier with revenue in the tens of millions and a specialized focus on injectable biologics and small-scale personalized medicine, BioConnection offers a compelling target for mid-size biotechs and pharma companies seeking flexible, efficient manufacturing, including PPQ-ready campaigns.